These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38973128)

  • 1. Uric acid and cardiovascular diseases: a reappraisal.
    Prabhakar AP; Lopez-Candales A
    Postgrad Med; 2024 Jul; ():1-9. PubMed ID: 38973128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid in metabolic syndrome: Does uric acid have a definitive role?
    Copur S; Demiray A; Kanbay M
    Eur J Intern Med; 2022 Sep; 103():4-12. PubMed ID: 35508444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why focus on uric acid?
    Johnson RJ
    Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.
    Nishizawa H; Maeda N; Shimomura I
    Hypertens Res; 2022 Apr; 45(4):635-640. PubMed ID: 35046512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases.
    Fiori E; De Fazio L; Pidone C; Perone F; Tocci G; Battistoni A; Barbato E; Volpe M; Gallo G;
    J Hypertens; 2024 Oct; 42(10):1665-1680. PubMed ID: 39051476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
    Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
    Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid lowering therapy in cardiovascular diseases.
    Volterrani M; Iellamo F; Sposato B; Romeo F
    Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications.
    Tripolino C; Ciaffi J; Ruscitti P; Giacomelli R; Meliconi R; Ursini F
    Front Med (Lausanne); 2021; 8():737573. PubMed ID: 34631755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
    Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
    Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia and Cardiovascular Disease.
    Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
    Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances on uric acid transporters.
    Xu L; Shi Y; Zhuang S; Liu N
    Oncotarget; 2017 Nov; 8(59):100852-100862. PubMed ID: 29246027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid, hyperuricemia and vascular diseases.
    Jin M; Yang F; Yang I; Yin Y; Luo JJ; Wang H; Yang XF
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):656-69. PubMed ID: 22201767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions.
    Yang S; Liu H; Fang XM; Yan F; Zhang Y
    Int Immunopharmacol; 2024 May; 132():111932. PubMed ID: 38560961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
    Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
    Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
    Soltani Z; Rasheed K; Kapusta DR; Reisin E
    Curr Hypertens Rep; 2013 Jun; 15(3):175-81. PubMed ID: 23588856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid and the risk of cardiovascular and renal disease.
    Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
    J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.